Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay

In dihydropteridine reductase assay the substrate quinonoid dihydropterine is reduced again to tetrahydropterine, concomitantly oxidizing NADH, the indicator of the enzyme assay. Because of the strong oxidizing capacity of quinonoid dihydropterine, the degree of spontaneous oxidation of NADH by the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inherited metabolic disease 1982-09, Vol.5 (3), p.132-136
Hauptverfasser: der Heiden, C., Brink, W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 136
container_issue 3
container_start_page 132
container_title Journal of inherited metabolic disease
container_volume 5
creator der Heiden, C.
Brink, W.
description In dihydropteridine reductase assay the substrate quinonoid dihydropterine is reduced again to tetrahydropterine, concomitantly oxidizing NADH, the indicator of the enzyme assay. Because of the strong oxidizing capacity of quinonoid dihydropterine, the degree of spontaneous oxidation of NADH by the various substances used in the dihydropterine reductase assay was studied spectrally. A high degree of spontaneous oxidation of NADH by the substrate itself was found, which can be regulated by dithiotreitol, dependent on its concentration. The absorbance increase at 336 nm, due to the non‐quinonoid dihydropterine formed spontaneously from its quinonoid form, strongly interferes with the absorbance decrease at 340 nm, due to the disappearance of NADH. The interference results in a shift of the absorbance maximum of NADH from 340 nm up to higher wavelengths. This phenomenon, expressing itself in various ways in blank and sample, is discussed with relevance to the validity of the current enzyme assays used in a further classification of hyperphenylalaninaemic patients.
doi_str_mv 10.1007/BF01800165
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80332727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80332727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2382-e3f3a438d336716c747613d9d69f108bc7dd004ea2432d443e5a87d2ec65dc2d3</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS1EFJZAQ4_kiiLSJP63twwJIYkCFEA98tp3tIaZ8cb2CA3VPgIlPEPeap8kk-zyU1Fd6Z7vnKurg9ALSo4oIfr49TmhhhCq5CM0o1LziiklH6MZoYJWZi7lE_Q05y-EkLmRch_tK8OI4GKGbj-uwJVkW5zL4ANkHBtcloBDXyBZV0Lsf6_ysMgTWgBv1j9vhtDHPga_Wf_CarP-0UFZji32YTn6FFeTO_SAbe8fvC5C_33sAL8_ObvAQwaPbcadTV8hTbcemH-t_t6cwA-u2DzF5GzHZ2ivsW2G57t5gD6fv_l0elFdf3h7eXpyXTnGDauAN9wKbjznSlPltNCKcj_3at5QYhZOe0-IAMsEZ14IDtIa7Rk4Jb1jnh-gV9vcVYo3A-RSdyE7aFvbQxxybQjnTDM9gYdb0KWYc4KmXqUw_TTWlNT3zdR_m5ngl7vUYdGB_4Puqph0stW_hRbG_yTVV5fvzgjljN8Bx36cww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80332727</pqid></control><display><type>article</type><title>Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>der Heiden, C. ; Brink, W.</creator><creatorcontrib>der Heiden, C. ; Brink, W.</creatorcontrib><description>In dihydropteridine reductase assay the substrate quinonoid dihydropterine is reduced again to tetrahydropterine, concomitantly oxidizing NADH, the indicator of the enzyme assay. Because of the strong oxidizing capacity of quinonoid dihydropterine, the degree of spontaneous oxidation of NADH by the various substances used in the dihydropterine reductase assay was studied spectrally. A high degree of spontaneous oxidation of NADH by the substrate itself was found, which can be regulated by dithiotreitol, dependent on its concentration. The absorbance increase at 336 nm, due to the non‐quinonoid dihydropterine formed spontaneously from its quinonoid form, strongly interferes with the absorbance decrease at 340 nm, due to the disappearance of NADH. The interference results in a shift of the absorbance maximum of NADH from 340 nm up to higher wavelengths. This phenomenon, expressing itself in various ways in blank and sample, is discussed with relevance to the validity of the current enzyme assays used in a further classification of hyperphenylalaninaemic patients.</description><identifier>ISSN: 0141-8955</identifier><identifier>EISSN: 1573-2665</identifier><identifier>DOI: 10.1007/BF01800165</identifier><identifier>PMID: 6820434</identifier><language>eng</language><publisher>Dordrecht: Kluwer Academic Publishers</publisher><subject>Buffers ; Dihydropteridine Reductase - metabolism ; Dithiothreitol - metabolism ; NAD - metabolism ; NADH, NADPH Oxidoreductases - metabolism ; Phosphates ; Potassium ; Potassium Compounds ; Pterins - metabolism ; Spectrophotometry, Ultraviolet ; Time Factors</subject><ispartof>Journal of inherited metabolic disease, 1982-09, Vol.5 (3), p.132-136</ispartof><rights>1982 SSIEM</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2382-e3f3a438d336716c747613d9d69f108bc7dd004ea2432d443e5a87d2ec65dc2d3</citedby><cites>FETCH-LOGICAL-c2382-e3f3a438d336716c747613d9d69f108bc7dd004ea2432d443e5a87d2ec65dc2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6820434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>der Heiden, C.</creatorcontrib><creatorcontrib>Brink, W.</creatorcontrib><title>Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay</title><title>Journal of inherited metabolic disease</title><addtitle>J Inherit Metab Dis</addtitle><description>In dihydropteridine reductase assay the substrate quinonoid dihydropterine is reduced again to tetrahydropterine, concomitantly oxidizing NADH, the indicator of the enzyme assay. Because of the strong oxidizing capacity of quinonoid dihydropterine, the degree of spontaneous oxidation of NADH by the various substances used in the dihydropterine reductase assay was studied spectrally. A high degree of spontaneous oxidation of NADH by the substrate itself was found, which can be regulated by dithiotreitol, dependent on its concentration. The absorbance increase at 336 nm, due to the non‐quinonoid dihydropterine formed spontaneously from its quinonoid form, strongly interferes with the absorbance decrease at 340 nm, due to the disappearance of NADH. The interference results in a shift of the absorbance maximum of NADH from 340 nm up to higher wavelengths. This phenomenon, expressing itself in various ways in blank and sample, is discussed with relevance to the validity of the current enzyme assays used in a further classification of hyperphenylalaninaemic patients.</description><subject>Buffers</subject><subject>Dihydropteridine Reductase - metabolism</subject><subject>Dithiothreitol - metabolism</subject><subject>NAD - metabolism</subject><subject>NADH, NADPH Oxidoreductases - metabolism</subject><subject>Phosphates</subject><subject>Potassium</subject><subject>Potassium Compounds</subject><subject>Pterins - metabolism</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Time Factors</subject><issn>0141-8955</issn><issn>1573-2665</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kb1uFDEUhS1EFJZAQ4_kiiLSJP63twwJIYkCFEA98tp3tIaZ8cb2CA3VPgIlPEPeap8kk-zyU1Fd6Z7vnKurg9ALSo4oIfr49TmhhhCq5CM0o1LziiklH6MZoYJWZi7lE_Q05y-EkLmRch_tK8OI4GKGbj-uwJVkW5zL4ANkHBtcloBDXyBZV0Lsf6_ysMgTWgBv1j9vhtDHPga_Wf_CarP-0UFZji32YTn6FFeTO_SAbe8fvC5C_33sAL8_ObvAQwaPbcadTV8hTbcemH-t_t6cwA-u2DzF5GzHZ2ivsW2G57t5gD6fv_l0elFdf3h7eXpyXTnGDauAN9wKbjznSlPltNCKcj_3at5QYhZOe0-IAMsEZ14IDtIa7Rk4Jb1jnh-gV9vcVYo3A-RSdyE7aFvbQxxybQjnTDM9gYdb0KWYc4KmXqUw_TTWlNT3zdR_m5ngl7vUYdGB_4Puqph0stW_hRbG_yTVV5fvzgjljN8Bx36cww</recordid><startdate>198209</startdate><enddate>198209</enddate><creator>der Heiden, C.</creator><creator>Brink, W.</creator><general>Kluwer Academic Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198209</creationdate><title>Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay</title><author>der Heiden, C. ; Brink, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2382-e3f3a438d336716c747613d9d69f108bc7dd004ea2432d443e5a87d2ec65dc2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Buffers</topic><topic>Dihydropteridine Reductase - metabolism</topic><topic>Dithiothreitol - metabolism</topic><topic>NAD - metabolism</topic><topic>NADH, NADPH Oxidoreductases - metabolism</topic><topic>Phosphates</topic><topic>Potassium</topic><topic>Potassium Compounds</topic><topic>Pterins - metabolism</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>der Heiden, C.</creatorcontrib><creatorcontrib>Brink, W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of inherited metabolic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>der Heiden, C.</au><au>Brink, W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay</atitle><jtitle>Journal of inherited metabolic disease</jtitle><addtitle>J Inherit Metab Dis</addtitle><date>1982-09</date><risdate>1982</risdate><volume>5</volume><issue>3</issue><spage>132</spage><epage>136</epage><pages>132-136</pages><issn>0141-8955</issn><eissn>1573-2665</eissn><abstract>In dihydropteridine reductase assay the substrate quinonoid dihydropterine is reduced again to tetrahydropterine, concomitantly oxidizing NADH, the indicator of the enzyme assay. Because of the strong oxidizing capacity of quinonoid dihydropterine, the degree of spontaneous oxidation of NADH by the various substances used in the dihydropterine reductase assay was studied spectrally. A high degree of spontaneous oxidation of NADH by the substrate itself was found, which can be regulated by dithiotreitol, dependent on its concentration. The absorbance increase at 336 nm, due to the non‐quinonoid dihydropterine formed spontaneously from its quinonoid form, strongly interferes with the absorbance decrease at 340 nm, due to the disappearance of NADH. The interference results in a shift of the absorbance maximum of NADH from 340 nm up to higher wavelengths. This phenomenon, expressing itself in various ways in blank and sample, is discussed with relevance to the validity of the current enzyme assays used in a further classification of hyperphenylalaninaemic patients.</abstract><cop>Dordrecht</cop><pub>Kluwer Academic Publishers</pub><pmid>6820434</pmid><doi>10.1007/BF01800165</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-8955
ispartof Journal of inherited metabolic disease, 1982-09, Vol.5 (3), p.132-136
issn 0141-8955
1573-2665
language eng
recordid cdi_proquest_miscellaneous_80332727
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Buffers
Dihydropteridine Reductase - metabolism
Dithiothreitol - metabolism
NAD - metabolism
NADH, NADPH Oxidoreductases - metabolism
Phosphates
Potassium
Potassium Compounds
Pterins - metabolism
Spectrophotometry, Ultraviolet
Time Factors
title Spectral studies of the interaction of the substrate ‘quinonoid’ 6‐methyl dihydropterine and the coenzyme NADH used as marker in the dihydropteridine reductase assay
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A13%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectral%20studies%20of%20the%20interaction%20of%20the%20substrate%20%E2%80%98quinonoid%E2%80%99%206%E2%80%90methyl%20dihydropterine%20and%20the%20coenzyme%20NADH%20used%20as%20marker%20in%20the%20dihydropteridine%20reductase%20assay&rft.jtitle=Journal%20of%20inherited%20metabolic%20disease&rft.au=der%20Heiden,%20C.&rft.date=1982-09&rft.volume=5&rft.issue=3&rft.spage=132&rft.epage=136&rft.pages=132-136&rft.issn=0141-8955&rft.eissn=1573-2665&rft_id=info:doi/10.1007/BF01800165&rft_dat=%3Cproquest_cross%3E80332727%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80332727&rft_id=info:pmid/6820434&rfr_iscdi=true